Overview

Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

Status:
Active, not recruiting

Trial end date:
2022-08-08

Target enrollment:

Participant gender:

Summary

The purpose of this study is to observe whether the Triptorelin pamoate 15mg (3-month formulation) effectiveness in Chinese population of CPP children has the same or similar trend with that in overseas CPP population. This is measured by assessing the proportion of children who have a suppressed Luteinizing Hormone (LH) response to Gonadotropin Releasing Hormone (GnRH) test performed 3 months after injection of triptorelin.

Phase:

Phase 3

Details

Lead Sponsor:

Ipsen

Treatments:

Triptorelin Pamoate